Dimension Therapeutics
Founded
2013
2013
Geography
United States of America based
United States of America based
Funding
$124.500 M
$124.500 M
Dimension Therapeutics is developing novel, liver-directed gene therapy treatments for severe, rare genetic disorders. Dimension’s lead programs address significant medical needs for new therapies and include a wholly owned program in hemophilia B.
Technologies
Gene Therapy StartupsR&D Platform
Pipelines
No pipelines published yet
Products
Services
No services posted yet
